Manage a Lifetime of Complex Projects for Only $40

Get a lifetime license for the Windows version of Microsoft Project Professional 2024 for just $39.97.

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Disease…

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Disease…

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Logistics Management

How top U.S. ports adapted to a year of redirected trade

The Top U.S. Ports report shows how shifting trade policy, volatile demand, and disrupted global routing reshaped import patterns in 2025, forcing ports to operate in near-constant adaptation mode.

Kick off your most productive year with MS Project 2024 for just $40

TL;DR: Get the latest Microsoft Project Professional 2024 for a one-time payment of $39.97 and take full control of every ...

Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO™ (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...